Hamilton Wealth LLC Purchases 9,136 Shares of Centene Corporation $CNC

Hamilton Wealth LLC grew its holdings in Centene Corporation (NYSE:CNC) by 128.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,246 shares of the company’s stock after acquiring an additional 9,136 shares during the quarter. Hamilton Wealth LLC’s holdings in Centene were worth $669,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Oracle Investment Management Inc. bought a new position in shares of Centene in the third quarter worth $3,936,000. Capitolis Liquid Global Markets LLC grew its stake in Centene by 451.2% during the third quarter. Capitolis Liquid Global Markets LLC now owns 181,900 shares of the company’s stock worth $6,490,000 after buying an additional 148,900 shares in the last quarter. Counterpoint Mutual Funds LLC increased its holdings in Centene by 161.1% in the 3rd quarter. Counterpoint Mutual Funds LLC now owns 91,943 shares of the company’s stock valued at $3,281,000 after buying an additional 56,730 shares during the period. Alberta Investment Management Corp raised its position in shares of Centene by 22.1% in the 3rd quarter. Alberta Investment Management Corp now owns 1,075,000 shares of the company’s stock valued at $38,356,000 after buying an additional 194,300 shares in the last quarter. Finally, Kennondale Capital Management LLC lifted its holdings in shares of Centene by 500.0% during the 3rd quarter. Kennondale Capital Management LLC now owns 48,978 shares of the company’s stock worth $1,748,000 after acquiring an additional 40,815 shares during the period. 93.63% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

CNC has been the topic of a number of recent analyst reports. Sanford C. Bernstein lifted their price objective on shares of Centene from $48.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, May 5th. UBS Group reiterated a “neutral” rating and issued a $61.00 price target (up from $55.00) on shares of Centene in a research note on Friday, May 22nd. Wells Fargo & Company raised their price objective on Centene from $44.00 to $56.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Cantor Fitzgerald reissued an “overweight” rating on shares of Centene in a research note on Thursday, June 11th. Finally, Bank of America raised their price target on shares of Centene from $72.00 to $74.00 and gave the company a “buy” rating in a research note on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $60.24.

Centene Stock Performance

NYSE CNC opened at $61.06 on Friday. The company has a market capitalization of $30.15 billion, a price-to-earnings ratio of -4.65, a PEG ratio of 0.47 and a beta of 1.09. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.55. The stock has a fifty day simple moving average of $53.52 and a 200 day simple moving average of $44.99.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, topping the consensus estimate of $2.23 by $1.14. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The firm had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. During the same period in the previous year, the business earned $2.90 EPS. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. Sell-side analysts expect that Centene Corporation will post 3.45 EPS for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.